Overview

Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer

Status:
Completed
Trial end date:
2001-01-01
Target enrollment:
0
Participant gender:
All
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy before and after surgery in treating patients with high-risk stomach cancer.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Calcium
Cisplatin
Floxuridine
Fluorouracil
Leucovorin
Levoleucovorin
Criteria
DISEASE CHARACTERISTICS: Microscopically confirmed adenocarcinoma of the stomach or
gastroesophageal junction Reviewed by Department of Pathology of participating institution
Stage II-IV (T2, N1-2, M0 or T3-4, any N, M0) by physical exam, CT, and laparoscopy
Potentially curable by surgery Suspected sites of metastasis proven M0 prior to entry

PATIENT CHARACTERISTICS: Age: Any age Performance status: Karnofsky 60%-100% Hematopoietic:
WBC at least 4,000 Platelets at least 150,000 Hepatic: Bilirubin less than 2 mg/dL Renal:
Creatinine no greater than 1.5 mg/dL OR Creatinine clearance greater than 50 mL/min BUN no
greater than 30 mg/dL Cardiovascular: No NYHA class III/IV status No active angina No
myocardial infarction within 6 months No significant ventricular arrhythmia requiring
medication No clinically significant conduction system abnormality Other: No serious
intercurrent infection No nonmalignant medical illness that is uncontrolled or precludes
study participation No psychiatric disorder that precludes informed consent No clinically
significant auditory impairment No second malignancy within 5 years except: Basal cell skin
cancer Carcinoma in situ of the cervix No pregnant or nursing women Negative pregnancy test
required of fertile women Effective contraception required of fertile patients

PRIOR CONCURRENT THERAPY: No prior chemotherapy or radiotherapy